SRDX
Surmodics Inc.
Company Overview
| Mkt Cap | $462.81M | Price | $28.32 |
| Volume | 117.06K | Change | +3.23% |
| P/E Ratio | -40.1 | Open | $27.59 |
| Revenue | $126.1M | Prev Close | $27.44 |
| Net Income | $-11.5M | 52W Range | $26.00 - $40.39 |
| Div Yield | N/A | Target | $43.00 |
| Overall | 47 | Value | 60 |
| Quality | 47 | Technical | 36 |
No chart data available
Stock Overview
Updated DailySurmodics Inc. (SRDX) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $28.32 with a market capitalization of $462.81 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating below-average quality metrics with a MarketXLS quality score of 47.
Today's trading session shows SRDX with a volume of 117K shares. The stock opened up 0.56% from yesterday's close of $27.43. Current analyst estimates project earnings of $-0.3 per share for this year, with next year targeting $-0.12.
SRDX demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including NKTR, TMO, ENZ, ALKS, ABT.
Key investment considerations for SRDX include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 51.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 08:52 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRDX | $28.32 | +3.2% | 117.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |